Merus Labs International Inc. Fund Company Profile

Description

Merus Labs International Inc., a specialty pharmaceutical company, engages in the acquisition of prescription medicines primarily in Canada and Europe. The company offers Sintrom, an anti-coagulant drug for the treatment and prevention of thromboembolism diseases; Emselex/Enablex, a prescription medicine for the treatment of urinary urgency and incontinence for adults; and Salagen, an oral tablet for the treatment of symptoms associated with radiation therapy. It also provides Vancocin, a capsule for the treatment of the Clostridium Difficile infection; and Estraderm, a hormone replacement therapy that contains the female hormone estrogen. The company is headquartered in Toronto, Canada.